Linezolid is the first of this new class of antibiotics. It has very broad activity against Gram-positive bacteria via a novel anti-ribosomal action. It was released to great “fanfare” as the solution to MRSA and VRE infections but resistance has already been described in both organisms. Its’ cost has ensured that it is judiciously used in Canada – $70.00 per tablet twice a day or $1400.00 for a 10 day course.

Category: Antibiotics

Other Notes